Title
Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia
Authoring Organization
Publication Month/Year
April 30, 2021
Last Updated Month/Year
October 4, 2024
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Document Objectives
This document provides evidence-based clinical practice guidelines on the diagnostic utility of nucleic acid–based testing of respiratory samples for viral pathogens other than influenza in adults with suspected community-acquired pneumonia (CAP).
Target Patient Population
Adults with suspected community-acquired pneumonia (CAP).
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Hospital, Laboratory services
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening
Diseases/Conditions (MeSH)
D011014 - Pneumonia, D021141 - Nucleic Acid Amplification Techniques
Keywords
community-acquired pneumonia, pneumonia, nucleic acid amplification test (NAAT), NAAT
Source Citation
Evans SE, Jennerich AL, Azar MM, Cao B, Crothers K, Dickson RP, Herold S, Jain S, Madhavan A, Metersky ML, Myers LC, Oren E, Restrepo MI, Semret M, Sheshadri A, Wunderink RG, Dela Cruz CS. Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021 May 1;203(9):1070-1087. doi: 10.1164/rccm.202102-0498ST. PMID: 33929301; PMCID: PMC8314899.